FRFrançoise Renard

Françoise Renard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Françoise Renard has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Assessing polypharmacy in the older population: Comparison of a self‐reported and prescription based method

    by Johan Van der Heyden, Finaba Berete, Françoise Renard, Johan Vanoverloop, Brecht Devleesschauwer, Karin De Ridder, Olivier Bruyère

    Purpose To explore differences in the prevalence and determinants of polypharmacy in the older general population in Belgium between self-reported and prescription based estimates and assess the relative merits of each data source. Methods Data were used from participants aged ≥ 65 years of the Belgian national health survey 2013 (n = 1950). Detailed information was asked on the use of medicines in the past 24 hours and linked with prescription data from the Belgian compulsory health insurance. Agreement between polypharmacy (use or prescription ≥ 5 medicines) and excessive polypharmacy (≥ 10 medicines) between both sources was assessed with kappa statistics. Multinomial logistic regression was used to study determinants of moderate (5-9 medicines) and excessive polypharmacy (≥ 10 medicines) and over- and underestimation of prescription based compared to self-reported polypharmacy. Results Self-reported and prescription based polypharmacy prevalence estimates were respectively 27% and 32%. Overall agreement was moderate, but better in men (kappa 0.60) than in women (0.45). Determinants of moderate polypharmacy did not vary substantially by source of outcome indicator, but restrictions in activities of daily living, living in an institution and a history of a hospital admission was associated with self-reported based excessive polypharmacy only. Conclusions Surveys and prescription data measure polypharmacy from a different perspective, but overall conclusions in terms of prevalence and determinants of polypharmacy do not differ substantially by data source. Linking survey data with prescription data can combine the strengths of both data sources resulting in a better tool to explore polypharmacy at population level.


  • Open Access

    Belgian COVID-19 Mortality, Excess Deaths, Number of Deaths per Million, and Infection Fatality Rates (8 March - 9 May 2020)

    by Geert Molenberghs, Christel Faes, Jan Aerts, Heidi Theeten, Brecht Devleesschauwer, Natalia Bustos Sierra, Toon Braeye, Françoise Renard, Sereina Herzog, Patrick Lusyne, et al.

    Objective: Scrutiny of COVID-19 mortality in Belgium over the period 8 March – 9 May 2020 (Weeks 11-19), using number of deaths per million, infection fatality rates, and the relation between COVID-19 mortality and excess death rates. Data: Publicly available COVID-19 mortality (2020); overall mortality (2009 – 2020) data in Belgium and demographic data on the Belgian population; data on the nursing home population; results of repeated sero-prevalence surveys in March-April 2020. Statistical methods: Reweighing, missing-data handling, rate estimation, visualization. Results: Belgium has virtually no discrepancy between COVID-19 reported mortality (confirmed and possible cases) and excess mortality. There is a sharp excess death peak over the study period; the total number of excess deaths makes April 2020 the deadliest month of April since WWII, with excess deaths far larger than in early 2017 or 2018, even though influenza-induced January 1951 and February 1960 number of excess deaths were similar in magnitude. Using various sero-prevalence estimates, infection fatality rates (IFRs; fraction of deaths among infected cases) are estimated at 0.38 - 0.73% for males and 0.20 – 0.39% for females in the non-nursing home population (non-NHP), and at 0.79 – 1.52% for males and 0.88 – 1.31% for females in the entire population. Estimates for the NHP range from 38 to 73% for males and over 22 to 37% for females. The IFRs rise from nearly 0% under 45 years, to 4.3% and 13.2% for males in the non-NHP and the general population, respectively, and to 1.5% and 11.1% for females in the non-NHP and general population, respectively. The IFR and number of deaths per million is strongly influenced by extensive reporting and the fact that 66.0% of the deaths concerned NH residents. At 764 (our re-estimation of the figure 735, presented by “Our World in Data”), the number of COVID-19 deaths per million led the international ranking on May 9, 2020, but drops to 262 in the non-NHP. The NHP is very specific: age-related increased risk; highly prevalent comorbidities that, while non-fatal in themselves, exacerbate COVID-19; larger collective households that share inadvertent vectors such as caregivers and favor clustered outbreaks; initial lack of protective equipment, etc. High-quality health care countries have a relatively older but also more frail population [1], which is likely to contribute to this result. Thumbnail summary: What this paper adds: COVID-19 mortality and its relation to excess deaths, case fatality rates (CFRs), infection fatality rates (IFRs), and number of deaths per million are constantly being reported for a large number of countries globally . This study adds detailed insight in the Belgian situation over the period 8 March – 9 May 2020 (Week 11–Week 19) . Belgium has virtually no discrepancy between COVID-19 reported mortality (confirmed and possible cases) and excess mortality. This, combined with a high fraction of possible cases that is COVID-19 related [2] provides a basis for using all COVID-19 cases and thus not only the confirmed ones, in IFR estimation . Against each of the years from 2009 and 2019 and the average thereof, there is a strong excess death peak in 2020, which nearly entirely coincides with confirmed plus possible COVID-19 cases. The excess death/COVID-19 peak rises well above seasonal fluctuations seen in the first trimester during the most recent decade (induced in part by seasonal influenza). In the second week of April 2020, twice as many people died than in the corresponding week of the reference year. April 2020 was the deadliest month of April since WWII, although January 1951 and February 1960 saw similar figures. More recently, in the winter of 2017-2018, there was 4 . 6% excess mortality in Belgium (70,215 actual deaths; 3093 more than the Be-MOMO-model prediction). In the winter of 2016-2017, there was an excess of 3284 deaths (4 . 9% excess mortality) https://epistat.wiv-isp.be/docs/momo/Be-MOMO%20winter%202017-18%20report_FR.pdf . At 764 (our estimate), the number of COVID-19 deaths per million leads the international ranking, but drops sharply to 262 in the non-nursing home population . CFR is not a good basis for international comparison, except as a tool in estimating global infection fatality rates [2]. These authors used asymptotic models to derive IFR as a limit of CFR. CFR is strongly influenced by testing strategy, and in several studies the delay between case confirmation and deaths is not accounted for. The handling of possible cases is ambiguous at best. We do not consider it here . Bias and precision in estimation of IFR is influenced by difficulties surrounding the estimation of sero-prevalence, such as sensitivity and specificity of the tests used [3], time to IgM and in particular IgG seroconversion [4], and potential selection bias occurring in data from residual sample surveys. A sensitivity analysis is undertaken by augmenting one primary with three auxiliary estimates of sero-prevalence . Because in Belgium there is a very close agreement between excess mortality on the one hand and confirmed and possible COVID-19 cases combined on the other, and because an international study [2] suggested that a fraction as high as 0 . 9 of possible cases could be attributable to COVID-19 [5], it is a reasonable choice to use all COVID-19 cases in IFR estimation. This encompasses a large fraction of deaths occurring in nursing homes. The IFR values obtained align with international values [2]. Using various sero-prevalence estimates, IFRs across all ages are estimated at 0 . 38 - 0 . 73% for males and 0 . 20 – 0 . 39% for females in the non-nursing home population (non-NHP), and at 0 . 79 – 1 . 52% for males and 0 . 88 – 1 . 31% for females in the entire population. Estimates for the NHP range from 38 to 73% for males and over 22 to 37% for females. The IFRs rise from nearly 0% under 45 years, to 4 . 3% and 13 . 2% for males in the non-NHP and the general population, respectively, and to 1 . 5% and 11 . 1% for females in the non-NHP and general population, respectively . The IFR is strongly influenced by extensive death cases reporting and the fact that 66 . 0% of the deaths concerned NH residents. Apart from a strong age-related gradient, also for each age category, IFRs are substantially higher in males than in females Because of these dependencies, IFRs should be considered in an age, gender, and sub-population specific manner. The same proviso is made for the number of deaths per million . An important such population is the NHP because of a specific cocktail: age-related increased risk; highly prevalent comorbidities that, while non-fatal in themselves, exacerbate COVID-19; larger collective households that share inadvertent vectors such as caregivers; initial lack of protective equipment, etc. High-quality health care countries have a relatively older but also more frail population [1], which might contribute .


  • Open Access

    Monitoring health inequalities when the socio-economic composition changes: are the slope and relative indices of inequality appropriate? Results of a simulation study

    by Françoise Renard, Brecht Devleesschauwer, Niko Speybroeck, Patrick Deboosere

    The slope (SII) and relative (RII) indices of inequality are commonly recommended to monitor health inequality policies. As an upwards shift of the educational level distribution (ELD) can be part of those policies, we examine how such a shift affects the SII, the RII and the population attributable fraction (PAF). We simulated 632 distributions of 4 educational levels (ELs) by varying the share (p1 to p4) of each EL, with constant mortality rates (MR) and calculated the corresponding RII, SII and PAF. Second, we decomposed the effect on the three indices of a change affecting both the ELD and the MRs, into the contributions of each component. RIIs and SIIs sharply increase with p4 at fixed p1 values and evolve as reversed U-curves for p1 changing in complement to p4. The RII reaches a maximum, at much higher p4 values than the SII. PAFs monotonically decrease when p4 increases. If improving the educational attainment is part of a policy, an upwards shift of EL should be assessed as a progress; however the RII, and to a lesser extent the SII, frequently translate an increased EL4 share as a worsening. We warn against the use of SII and RII for monitoring inequality-tackling policies at changing socio-economic structures. Rather, we recommend to complement the assessment of changes in absolute and relative pairwise differentials, with changes in PAF and in the socio-economic group shares.


  • Open Access

    Evolution of educational inequalities in life and health expectancies at 25 years in Belgium between 2001 and 2011: a census-based study

    by Françoise Renard, Brecht Devleesschauwer, Herman Van Oyen, Sylvie Gadeyne, Patrick Deboosere

    Reducing socio-economic health inequalities is a public health priority, necessitating careful monitoring that should take into account changes in the population composition. We analyzed the evolution of educational inequalities in life expectancy and disability-free life expectancy at age 25 (LE25 and DFLE25) in Belgium between 2001 and 2011. The 2001 and 2011 census data were linked with the national register data for a five-year mortality follow up. Disability prevalence estimates from the health interview surveys (2001 to 2013) were used to compute DFLE according to Sullivan’s method. LE25 and DFLE25 were computed by educational level (EL). Absolute differentials of LE25 and DFLE25 were calculated for each EL and for each period, as well as composite inequality indices (CII) of population-level impact of inequality. Changes over the 10-year period were then calculated for each inequality index. The LE25 increased in all ELs and both genders, except in the lowest EL for women. The increase was larger in the highest EL, leading in 2011 to 6.07 and 4.58 years for the low-versus-high LE25 gaps respectively in men and women, compared to 5.19 and 3.76 in 2001, namely 17 and 22% increases. The upwards shift of the EL distribution led to a limited 7% increase of the CII among men but no change in women. The substantial increase of the DFLE25 in males with high EL (+ 4.5 years) and the decrease of the DFLE25 in women with low EL, results in a substantial increase of all considered DFLE25 inequality measures in both genders. In 2011, DFLE25 gaps were respectively 10.4 and 13.5 years in males and females compared to 6.51 and 9.30 in 2001, representing increases of 61 and 44% for the gaps, and 72 and 20% for the CII. The LE25 increased in all ELs, but at a higher pace in highly educated, leading to an increase in the LE25 gaps in both genders. After accounting for the upwards shift of the educational distribution, the population-level inequality index increased only for men. The DFLE25 increased only in highly educated men, and decreased in low educated women, leading to large increases of inequalities in both genders. A general plan to tackle health inequality should be set up, with particular efforts to improve the health of the low educated women.


  • Open Access

    Educational inequalities in premature mortality by region in the Belgian population in the 2000s

    by Françoise Renard, Brecht Devleesschauwer, Sylvie Gadeyne, Jean Tafforeau, Patrick Deboosere

    In Belgium, socio-economic inequalities in mortality have long been described at country-level. As Belgium is a federal state with many responsibilities in health policies being transferred to the regional levels, regional breakdown of health indicators is becoming increasingly relevant for policy-makers, as a tool for planning and evaluation. We analyzed the educational disparities by region for all-cause and cause-specific premature mortality in the Belgian population. Residents with Belgian nationality at birth registered in the census 2001 aged 25–64 were included, and followed up for 10 years though a linkage with the cause-of-death database. The role of 3 socio-economic variables (education, employment and housing) in explaining the regional mortality difference was explored through a Poisson regression. Age-standardised mortality rates (ASMRs) by educational level (EL), rate differences (RD), rate ratios (RR), and population attributable fractions (PAF) were computed in the 3 regions of Belgium and compared with pairwise regional ratios. The global PAFs were also decomposed into the main causes of death. Regional health gaps are observed within each EL, with ASMRs in Brussels and Wallonia exceeding those of Flanders by about 50% in males and 40% in females among Belgian. Individual SE variables only explained up to half of the regional differences. Educational inequalities were also larger in Brussels and Wallonia than in Flanders, with RDs ratios reaching 1.8 and 1.6 for Brussels versus Flanders, and Wallonia versus Flanders respectively; regional ratios in relative inequalities (RRs and PAFs) were smaller. This pattern was observed for all-cause and most specific causes of premature mortality. Ranking the cause-specific PAFs revealed a higher health impact of inequalities in causes combining high mortality rate and relative inequality, with lung cancer and ischemic heart disease on top for all regions and both sexes. The ranking showed few regional differences. For the first time in Belgium, educational inequalities were studied by region. Among the Belgian, educational inequalities were higher in Brussels, followed by Wallonia and Flanders. The region-specific PAF decomposition, leading to a ranking of causes according to their population-level impact on overall inequality, is useful for regional policy-making processes.


  • Open Access

    Mapping the cause-specific premature mortality reveals large between-districts disparity in Belgium, 2003–2009

    by Françoise Renard, Jean Tafforeau, Patrick Deboosere

    Reducing premature mortality is a crucial public health objective. The goal of this paper, beside updating previous mortality atlases with recent data, is to explore the relative between-districts disparity using a relative-scale map design. Causes of deaths and population data were provided by Statistics Belgium. All deaths occurring in the periods 1993–1999 and 2003–2009, in people aged 1–74 residing in Belgium were included. Age-adjusted rates by cause of death were computed for both periods; the 2003-2009 rates were classified using a relative scale with a 10% change between each level and represented on chloropleths maps with a green-to-red divergent colour scheme centred on the national mean. This particular design allows the comparability across all the maps since a same meaning is given to a specific colour. The variation coefficient and the decile ratio were calculated and compared between the 2 periods. A clear-cut regional divide at the disadvantage of Wallonia, and to some extent, of Brussels, was seen for all-cause, cardiovascular, cerebrovascular, diabetes, alcohol-related, mental and neurological diseases and non-transport accidents premature mortality. A NE-SW pattern parallel to the French border was observed for Lip, Oral Cavity, Pharynx, Larynx and oesophageal cancers, while various patterns are observed for the other cancers. The highest rates of road accident mortality are observed in the Southern districts. Many of those patterns are in continuity with earlier observations. However, the pattern of diabetes and mental and neurological diseases are new features. The variation coefficient and the decile ratios increased by 10% between the 1993-1997 and 2003-2009 periods. The use of a relative scale in the maps highlights the importance of the between-districts disparity in premature mortality, with for most causes, a clear-cut regional divide at the disadvantage of Wallonia; this health gap results of complex interactions between various factors, including the socioeconomic context, cultural habits and environmental influences, as well as public health policies. It should be considered as a warning signal, warranting the attention of the policy makers. Meanwhile, these results also highlight the potential for improvement in the more disadvantaged regions.


  • Open Access

    Premature mortality in Belgium in 1993-2009: leading causes, regional disparities and 15 years change

    by Françoise Renard, Jean Tafforeau, Patrick Deboosere

    Reducing premature mortality is a crucial public health objective. After a long gap in the publication of Belgian mortality statistics, this paper presents the leading causes and the regional disparities in premature mortality in 2008–2009 and the changes since 1993. All deaths occurring in the periods 1993–1999 and 2003–2009, in people aged 1–74 residing in Belgium were included. The cause of death and population data for Belgium were provided by Statistics Belgium , while data for international comparisons were extracted from the WHO mortality database. Age-adjusted mortality rates and Person Year of Life Lost (PYLL) were calculated. The Rate Ratios were computed for regional and international comparisons, using the region or country with the lowest rate as reference; statistical significance was tested assuming a Poisson distribution of the number of deaths. The burden of premature mortality is much higher in men than in women (respectively 42% and 24% of the total number of deaths). The 2008–9 burden of premature mortality in Belgium reaches 6410 and 3440 PYLL per 100,000, respectively in males and females, ranking 4th and 3rd worst within the EU15. The disparities between Belgian regions are substantial: for overall premature mortality, respective excess of 40% and 20% among males, 30% and 20% among females are observed in Wallonia and Brussels as compared to Flanders. Also in cause specific mortality, Wallonia experiences a clear disadvantage compared to Flanders. Brussels shows an intermediate level for natural causes, but ranks differently for external causes, with less road accidents and suicide and more non-transport accidents than in the other regions. Age-adjusted premature mortality rates decreased by 29% among men and by 22% among women over a period of 15 years. Among men, circulatory diseases death rates decreased the fastest (-43.4%), followed by the neoplasms (-26.6%), the other natural causes (-21.0%) and the external causes (-20.8%). The larger decrease in single cause is observed for stomach cancer (-48.4%), road accident (-44%), genital organs (-40.4%) and lung (-34.6%) cancers. On the opposite, liver cancer death rate increased by 16%. Among female, the most remarkable feature is the 50.2% increase in the lung cancer death rate. For most other causes, the decline is slightly weaker than in men. Despite a steady decrease over time, international comparisons of the premature mortality burden highlight the room for improvement in Belgium. The disadvantage in Wallonia and to some extent in Brussels suggest the role of socio-economic factors; well- designed health policies could contribute to reduce the regional disparities. The increase in female lung cancer mortality is worrying.


  • Open Access

    Using multiple measures to assess changes in social inequalities for breast cancer screening

    by Françoise Renard, Stefaan Demarest, Herman Van Oyen, Jean Tafforeau

    Objectives: To identify changes in social inequalities for mammograms uptake in Belgium over the period 1997–2008 using multiple indices, and to assess the contribution of the national breast cancer screening programme in these changes. Methods: Data were obtained from four waves of the Belgian Health Interview Survey. The socio-economic position was defined by the educational level. Inequalities were measured both with pairwise measures comparing extreme educational groups (prevalence difference and prevalence ratio), and with indices measuring the total inequality impact at population level: the Population Attributable Fraction (PAF), the Relative Index of Inequality (RII) and the Slope Index of Inequality (SII). Results: All indices show a substantial decrease in inequalities in mammographic uptake between 1997 and 2008. For the indices of total impact (PAF, RII, SII), the change occurred between the first two waves (1997 and 2001) and stabilized afterwards, while for pairwise indices the evolution continued over the whole period. Conclusion: Using multiple indices of inequality is necessary for a more complete understanding of the changes: total impact inequality indices should always complement simple pairwise measures. The inequalities in mammograms uptake, as measured with total impact indices, only decreased before the start of the national screening programme.


  • Open Access

    High burden of breast cancer in Belgium: recent trends in incidence (1999-2006) and historical trends in mortality (1954-2006)

    by Françoise Renard, Liesbet Van Eycken, Marc Arbyn

    In Belgium, breast cancer mortality has been monitored since 1954, whereas cancer incidence data have only been made available for a few years. In this article we update historical trends of breast cancer mortality and describe the recent breast cancer incidence.